Find the right Medicare plan for 2025 — compare coverage and costs in minutes.

Compare Medicare Plans →
Medicare News MedCity News

Kardigan’s IPO Lands $400M for Drugs That Get to Root Causes of Heart Diseases

Kardigan was able to upsize its IPO, raising more cash for three drug candidates in mid-stage clinical development for cardiovascular conditions with no available therapies. All three programs are expected to report key data in 2027 that could pave the way for Phase 3 testing. The post Kardigan’s IPO Lands $400M for Drugs That Get to Root Causes of Heart Diseases appeared first on MedCity News .

Read full article →
Medicare News MedCity News

Researchers Say Whole-Body MRI Companies Are Inflating the Scans’ Medical Benefits

A recent JAMA editorial from two radiologists argues that elective whole-body MRI scan companies are misleading consumers about the benefits of said scans. The radiologists argue the MRIs are more likely to trigger harmful downstream procedures than they are to save lives. Not surprisingly, the three most prominent companies offering these scans denied the charge. The post Researchers Say Whole-Body MRI Companies Are Inflating the Scans’ Medical Benefits appeared first on MedCity News .

Read full article →
Medicare News KFF Health News

Arrests of Immigrant Parents Create Mental Health Crisis for Children

An estimated hundreds of thousands of children, many of them U.S. citizens, have been separated from a parent in the Trump administration’s immigration crackdown. Their distress manifests in physical and mental health symptoms including developmental regression, stomachaches, sleep problems, and falling grades. Research points to long-term health consequences.

Read full article →
Medicare News MedCity News

KFF: Insurer Participation in ACA Marketplaces Is Down

KFF’s analysis found that the average number of issuers offering plans on the Marketplaces declined to 9 issuers per state in 2026, compared to 9.6 issuers per state in 2025. The post KFF: Insurer Participation in ACA Marketplaces Is Down appeared first on MedCity News .

Read full article →
Medicare News MedCity News

FDA Reversal on uniQure Gene Therapy Is Another Sign of Renewed Regulatory Flexibility

UniQure is preparing to seek accelerated FDA approval for its Huntington’s disease gene therapy, a move that follows the FDA’s reversal of its prior position calling for another clinical trial. This gene therapy is the latest in a growing list of rare disease treatments to receive reconsideration from an FDA that appears to be swinging back to regulatory flexibility. The post FDA Reversal on uniQure Gene Therapy Is Another Sign of Renewed Regulatory Flexibility appeared first on MedCity News .

Read full article →